Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 31, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Suji Jeong Initiated (STOK) at Strong Buy and Held Target at $50 on, Jan 31st, 2022
Suji Jeong of Jefferies, Initiated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $50 on, Jan 31st, 2022.
Suji has made no other calls on STOK in the last 4 months.
There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Suji's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Suji
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $43 on, Friday, December 3rd, 2021
- Jessica Fye of "JP Morgan" Upgraded from Hold to Buy and Held Target at $41 on, Monday, November 22nd, 2021
